Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03114228
Title An Expanded Treatment Protocol (ETP) of Midostaurin (PKC412) in Patients 18 Years of Age or Older With Newly-diagnosed FLT3-mutated Acute Myeloid Leukemia (AML)
Recruitment No longer available
Gender both
Phase Expanded access
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals

acute myeloid leukemia



Age Groups: senior | adult
Covered Countries CAN

Additional content available in CKB BOOST